211 related articles for article (PubMed ID: 28439875)
1. Epigenetic repression of miR-375 is the dominant mechanism for constitutive activation of the PDPK1/RPS6KA3 signalling axis in multiple myeloma.
Tatekawa S; Chinen Y; Ri M; Narita T; Shimura Y; Matsumura-Kimoto Y; Tsukamoto T; Kobayashi T; Kawata E; Uoshima N; Taki T; Taniwaki M; Handa H; Iida S; Kuroda J
Br J Haematol; 2017 Aug; 178(4):534-546. PubMed ID: 28439875
[TBL] [Abstract][Full Text] [Related]
2. Phosphoinositide protein kinase PDPK1 is a crucial cell signaling mediator in multiple myeloma.
Chinen Y; Kuroda J; Shimura Y; Nagoshi H; Kiyota M; Yamamoto-Sugitani M; Mizutani S; Sakamoto N; Ri M; Kawata E; Kobayashi T; Matsumoto Y; Horiike S; Iida S; Taniwaki M
Cancer Res; 2014 Dec; 74(24):7418-29. PubMed ID: 25269480
[TBL] [Abstract][Full Text] [Related]
3. The Rationale for the Dual-Targeting Therapy for RSK2 and AKT in Multiple Myeloma.
Isa R; Horinaka M; Tsukamoto T; Mizuhara K; Fujibayashi Y; Taminishi-Katsuragawa Y; Okamoto H; Yasuda S; Kawaji-Kanayama Y; Matsumura-Kimoto Y; Mizutani S; Shimura Y; Taniwaki M; Sakai T; Kuroda J
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328342
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic silencing of LPP/miR-28 in multiple myeloma.
Li Z; Wong KY; Chan GC; Chim CS
J Clin Pathol; 2018 Mar; 71(3):253-258. PubMed ID: 28775176
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic silencing of EVL/miR-342 in multiple myeloma.
Li Z; Wong KY; Chan GC; Chng WJ; Chim CS
Transl Res; 2018 Feb; 192():46-53. PubMed ID: 29242101
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic silencing of miR-340-5p in multiple myeloma: mechanisms and prognostic impact.
Li Z; Wong KY; Calin GA; Chng WJ; Chan GC; Chim CS
Clin Epigenetics; 2019 May; 11(1):71. PubMed ID: 31064412
[TBL] [Abstract][Full Text] [Related]
7. Insights into epigenetic regulation of microRNA-155 expression in multiple myeloma.
Krzeminski P; Sarasquete ME; Misiewicz-Krzeminska I; Corral R; Corchete LA; Martín AA; García-Sanz R; San Miguel JF; Gutiérrez NC
Biochim Biophys Acta; 2015 Mar; 1849(3):353-66. PubMed ID: 25497370
[TBL] [Abstract][Full Text] [Related]
8. Phosphoinositide-dependent protein kinase 1 is a potential novel therapeutic target in mantle cell lymphoma.
Maegawa S; Chinen Y; Shimura Y; Tanba K; Takimoto T; Mizuno Y; Matsumura-Kimoto Y; Kuwahara-Ota S; Tsukamoto T; Kobayashi T; Horiike S; Taniwaki M; Kuroda J
Exp Hematol; 2018 Mar; 59():72-81.e2. PubMed ID: 29287939
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional dysregulation of the deleted in colorectal carcinoma gene in multiple myeloma and monoclonal gammopathy of undetermined significance.
Nagoshi H; Taki T; Chinen Y; Tatekawa S; Tsukamoto T; Maegawa S; Yamamoto-Sugitani M; Tsutsumi Y; Kobayashi T; Matsumoto Y; Horiike S; Okuno Y; Fujiwara S; Hata H; Kuroda J; Taniwaki M
Genes Chromosomes Cancer; 2015 Dec; 54(12):788-95. PubMed ID: 26390996
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes.
Frassanito MA; Desantis V; Di Marzo L; Craparotta I; Beltrame L; Marchini S; Annese T; Visino F; Arciuli M; Saltarella I; Lamanuzzi A; Solimando AG; Nico B; De Angelis M; Racanelli V; Mariggiò MA; Chiacchio R; Pizzuti M; Gallone A; Fumarulo R; D'Incalci M; Vacca A
J Pathol; 2019 Feb; 247(2):241-253. PubMed ID: 30357841
[TBL] [Abstract][Full Text] [Related]
11. miR-15a and miR-16 affect the angiogenesis of multiple myeloma by targeting VEGF.
Sun CY; She XM; Qin Y; Chu ZB; Chen L; Ai LS; Zhang L; Hu Y
Carcinogenesis; 2013 Feb; 34(2):426-35. PubMed ID: 23104180
[TBL] [Abstract][Full Text] [Related]
12. EWSR1 overexpression is a pro-oncogenic event in multiple myeloma.
Nishiyama D; Chinen Y; Isa R; Fujibayashi Y; Kuwahara-Ota S; Yamaguchi J; Takimoto-Shimomura T; Matsumura-Kimoto Y; Tsukamoto T; Shimura Y; Kobayashi T; Horiike S; Taniwaki M; Handa H; Kuroda J
Int J Hematol; 2021 Mar; 113(3):381-394. PubMed ID: 33095415
[TBL] [Abstract][Full Text] [Related]
13. [Aberrant micro RNA and epigenetic network are associated with progression from MGUS to multiple myeloma].
Handa H
Rinsho Ketsueki; 2015 Aug; 56(8):981-8. PubMed ID: 26345556
[TBL] [Abstract][Full Text] [Related]
14. Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance.
Kubiczkova L; Kryukov F; Slaby O; Dementyeva E; Jarkovsky J; Nekvindova J; Radova L; Greslikova H; Kuglik P; Vetesnikova E; Pour L; Adam Z; Sevcikova S; Hajek R
Haematologica; 2014 Mar; 99(3):511-8. PubMed ID: 24241494
[TBL] [Abstract][Full Text] [Related]
15. Frequent methylation of the tumour suppressor miR-1258 targeting PDL1: implication in multiple myeloma-specific cytotoxicity and prognostification.
Wang LQ; Kumar S; Calin GA; Li Z; Chim CS
Br J Haematol; 2020 Jul; 190(2):249-261. PubMed ID: 32079038
[TBL] [Abstract][Full Text] [Related]
16. Aberrant Levels of miRNAs in Bone Marrow Microenvironment and Peripheral Blood of Myeloma Patients and Disease Progression.
Wang W; Corrigan-Cummins M; Barber EA; Saleh LM; Zingone A; Ghafoor A; Costello R; Zhang Y; Kurlander RJ; Korde N; Roccaro AM; Ghobrial IM; Landgren O; Calvo KR
J Mol Diagn; 2015 Nov; 17(6):669-78. PubMed ID: 26433312
[TBL] [Abstract][Full Text] [Related]
17. A new and important relationship between miRNA-147a and PDPK1 in radiotherapy.
Wang LJ; Li NN; Xu SJ; Zhang F; Hao MH; Yang XJ; Cai XH; Qiu PY; Ji HL; Xu P
J Cell Biochem; 2018 Apr; 119(4):3519-3527. PubMed ID: 29144017
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma.
Bi C; Chung TH; Huang G; Zhou J; Yan J; Ahmann GJ; Fonseca R; Chng WJ
Oncotarget; 2015 Sep; 6(28):26508-18. PubMed ID: 26164366
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic silencing of MIR203 in multiple myeloma.
Wong KY; Liang R; So CC; Jin DY; Costello JF; Chim CS
Br J Haematol; 2011 Sep; 154(5):569-78. PubMed ID: 21707582
[TBL] [Abstract][Full Text] [Related]
20. Infrequent DNA methylation of miR-9-1 and miR-9-3 in multiple myeloma.
Zhang Q; Wang LQ; Wong KY; Li ZY; Chim CS
J Clin Pathol; 2015 Jul; 68(7):557-61. PubMed ID: 25855800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
